NCT06791148View on ClinicalTrials.gov

Low-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in Patients With Advanced G/GEJ Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

July 10, 2024

Primary Completion Date

July 10, 2027

Study Completion Date

December 10, 2027

Conditions
Gastric Cancer
Interventions
RADIATION

Low-dose radiotherapy

2Gy/f，q3w，×4f

DRUG

albumin-bound paclitaxel

100-120mg/m2,i.v.,d2,d9,q3w

DRUG

AK112

20mg/kg, i.v., d2, q3w

Trial Locations (1)

Unknown

RECRUITING

Nanjing Drum Tower Hospital, Nanjing

All Listed Sponsors
lead

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER